Condition: Hiv · Visceral Leishmaniasis · Sponsor: Institute of Tropical Medicine, Belgium
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
This description comes directly from the study's public registry record.
Nicole Berens-Riha · 0460850115 · nberens@itg.be
Johan van Griensven · jvangriensven@itg.be
Always discuss trial participation with your own doctor first.
| University of Gondar | Gonder, Ethiopia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07487350